Unleash the Targeted Drug Potential of Biomolecules!
Biomolecules potential as a targeted drug against a variety of diseases is emphasized by the rapid development of the mRNA Covid-19 vaccines. Next to oligonucleotides, monoclonal antibodies (mAbs) are another class of biomolecules with multiple therapeutic products on the market. Thermo Scientific has over 20 years of innovations and publications around the separation and characterization of monoclonal antibodies and oligonucleotides.
In this webinar, we will present new findings on:
- High resolution separations of charge variants of mAb-drug candidates, in a more standardized chromatographic workflow
- Optimized digestion protocol for mAb-drug candidate peptide sequencing
- LC/MS analysis of oligonucleotides
Please join our webinar to learn how the MAbPac™, ProPac™, DNAPac™ family of reversed phase and ion exchange columns, as well as the SMART Digest™ trypsin kits, can help optimize and enhance your biotherapeutic separations.
Presenter: Robert van Ling
Robert is one of our go-to technical experts with 25+ years of experience with chromatographic separation and characterization of biomolecules. Starting in 1995, in the then still young field of proteomics, he has worked extensively with researchers in protein and antibody and oligonucleotide characterization. Robert is keen to share his knowledge about analytical separations and their challenges with you during this webinar.
